This review highlights recent advances in breast cancer diagnosis, and treatment, including precision medicine, artificial intelligence, and discusses how these developments could improve cancer care in Africa.
Abstract
Simple Summary Breast cancer is the most diagnosed cancer in women worldwide and is becoming an increasing health challenge across Africa. Although many scientific advances have improved how breast cancer is detected and treated, women in many African countries continue to experience poorer outcomes because cancers are often diagnosed at a later stage and access to specialised care, molecular testing, and modern therapies remains limited. At the same time, African populations are underrepresented in much of the research that guides current clinical practice, making it difficult to ensure that new technologies are equally effective for all patients. This review highlights recent advances in breast cancer diagnosis, and treatment, including precision medicine, artificial intelligence, and discusses how these developments could improve cancer care in Africa. We also explore the challenges that must be addressed to ensure equitable access to embed these new technologies in clinical practice. By increasing African participation in research and developing healthcare solutions that are tailored to local needs, these advances have the potential to improve earlier diagnosis, support more personalised treatment, and ultimately reduce breast cancer deaths across the continent.
It is observed that South Asian American women were diagnosed at younger ages, more frequently presented with aggressive forms of the disease, and experienced longer delays before starting treatment, although delays before surgery were associated with higher mortality.
J. Hundal, Ishan Gupta, Ashiya Loomba et al.· Cancers· 0 citations
Cancer remains a major public health challenge across BRICS member countries. Together, these countries represent more than 40% of the global population and account for approximately 9.0 million new cancer cases and 4.66 million cancer deaths. This review aims to summarize cancer epidemiology across the 11 BRICS member...
Ashok Sharma, Alisha Behera, Sahar Qazi et al.· The BRICS Health Journal· 0 citations
Among breast cancer patients, diagnostics differs depending on the disease stage that patients are in because in every disease stage other forms of diagnostics can be considered to be more precise. Whereas some forms of diagnostics are particularly effective in early-stage breast cancer identification, others are more...
H. Buiting· Southern medical journal (Bi...· 0 citations
One-Stop Breast Clinics (OSBCs) have emerged as a model of rapid diagnosis and streamlined care, enabling breast cancer patients to undergo assessment, diagnosis, and overview of treatment planning within a single day. This literature review examined the current implementation of breast clinics in Sri Lanka, analysing...
C. Kasturi, K. D. De Silva, J. Saunders· Galle Medical Journal· 0 citations
The barriers to clinical trial participation in pancreatic cancer across the patient pathway, from referral to enrolment are reviewed and coordinated improvements in referral, molecular testing, eligibility criteria, trial design, and delivery are identified as key strategies to improve equitable access to clinical tri...
Sue-Sien Thang, Daniel Croagh, Sumitra S. Ananda et al.· Communications Medicine· 0 citations
Breast cancer is one of the most commonly diagnosed malignancies among women worldwide and is frequently curable when identified at an early stage. However, advanced and metastatic disease continue to account for a substantial proportion of breast cancer-related deaths, particularly among patients with aggressive subty...
Shayla Murray, Matthew Becker, B. Lim· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.